Dermatology

Patients with skin of color (SOC) face disproportionately high rates of morbidity and mortality from melanoma. Increasing the awareness of disparities in melanoma recognition and improving diagnostic strategies are key to improving the outcomes of melanoma. Melanoma is a relatively common skin cancer that affects all groups of people in the United States. However, the...

The administration of prenatal antibiotics in the 3rd trimester of pregnancy in women over 30 years of age is significantly associated with the onset of AD in the offspring. Initiating in utero, the human microbiome is integral to the normal metabolic and immune function later in life. Microbial exposure is influenced by antibiotic use, breastfeeding,...

Dupilumab is effective for improving quality of life, sleep, and signs and symptoms of AD in children aged 6-11 years. Atopic dermatitis (AD) is the most prevalent inflammatory skin condition in infants and children. AD appears within six months of age in 45% of cases, less than one year of age in 60% of cases,...

The prevalence of infertility is greater among individuals with AD as compared to healthy individuals without AD. Infertility is the failure to achieve a clinical pregnancy after 12 months or more of unprotected sexual intercourse. A decline in fertility rates is a significant public health concern. Infertility affects approximately 10–15% of couples across the globe....

Individuals with AD are at relatively significant risk for the development of concomitant ED, hence, it is important to remain vigilant of the cutaneous manifestations of ED Atopic dermatitis (AD) is a prevalent inflammatory skin disorder that impairs the quality of life of both the patient and the caregiver to a significant extent. This inflammatory...

Patients with alopecia areata (AA) may have an increased risk of endothelial dysfunction and subsequent cardiovascular complications. A case-control study found that patients with AA had lower reactive hyperemia index (RHI) scores than patients without AA, indicating the potential need for routine cardiovascular screening in patients with AA. As a chronic autoimmune disease, alopecia areata...

Shared decision-making (SDM) is a crucial aspect of ensuring patients with alopecia areata (AA) are satisfied with the quality of their treatment. Clinicians are encouraged to implement SDM as often as possible when devising a treatment strategy for patients with AA. The treatment landscape for alopecia areata (AA) can be complex to navigate. With several...

Racial disparities can act as a barrier to appropriate access to care in pediatric patients with vitiligo and alopecia areata. Virtual group visits may help fill the gap in access to care among pediatric patients of color. Vitiligo and alopecia areata (AA) disproportionately affect the mental and emotional health of pediatric patients of color. Racial...

Patients with alopecia areata (AA) may be at a higher risk of mental health problems, such as anxiety and depression. As mental health conditions may have a negative effect on patient satisfaction scores, it is important for clinicians to tailor their communication strategies to address mental health and improve satisfaction in patients with AA. Patient...